Delivery Order SPE2DB22D9225-SPE2DB25FR8EU

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $6,764.72 contract is for the supply of a prescription drug, Cosentyx 150 mg/mL. DMS Pharmaceutical Group is the prime contractor, and there are no set-aside designations noted. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999, which allows the DLA to issue...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,911.80 contract is for the delivery of Cosentyx Unoready 300 mg pens to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of October 23, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,382.36, is for the delivery of 4,568,020,330 units of the prescription drug Cosentyx (300 mg/2 mL) by April 22, 2025. The contract type is firm fixed price. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,382.36, is for the delivery of Cosentyx (secukinumab) 300 mg pens to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,464.37 firm fixed-price delivery order is for the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML, with a completion date of June 18, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,382.36 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $5,100.90 delivery order is for the pharmaceutical product "COSENTYX SNRDY 300MG DOSE-2PENML" and has a completion date of July 30, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $34,859.08 contract is for the supply of Cosentyx, a prescription medication, to support the medical needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the delivery of Cosentyx (secukinumab) 300 mg pens, with a completion date of January 12, 2024 and a potential value of $3,382.36. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides a wide range of brand name and generic prescription and over-the-counter drug supplies to the U.S. Department of...
The Defense Logistics Agency awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide Cosentyx (secukinumab) 300 mg/2 mL injectable pens. The contract has a potential value of $3,382.36 and a completion date of January 3, 2024. DMS Pharmaceutical Group is a pharmaceutical wholesaler that holds multiple federal contracts and Indefinite Delivery Vehicles (IDVs) to supply a variety of pharmaceutical and medical products to support...
  • SPE2DB22D9225
    Indefinite Delivery Contract
  • SPE2DB22D9225-SPE2DB25FR8EU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,800.32 firm fixed-price contract is for the delivery of Cosentyx, a prescription medication, and has an ultimate completion date of April 30, 2025.

DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 7/29/25, 10:03 AM